The present application discloses novel 2-morpholino-3-amido-pyhcline derivatives and their use as modulators of the voltage gated K
v
7 (KCNQ) potassium ion channels in the treatment of pain, neurodegenerative disorders, urinary incontinence, etc. . . . . In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds.
本申请公开了新型2-吗啉基-3-酰胺基
吡啶衍生物及其在治疗疼痛、神经退行性疾病、尿失禁等方面作为电压门控Kv7(KCNQ)
钾离子通道调节剂的用途。此外,该申请还公开了这些化合物的用途,用于治疗方法和包含这些化合物的药物组合物。